Sanatorio Finochietto

Caba, Buenos Aires C1213

1 studies enrolling now · 2 studies all time

What they study most

Advanced Melanoma, Cardiovascular Risk, Chronic Kidney Disease, Inflammation

Studies at this site

• IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301) — Recruiting now
• ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation — Completed